MitoRx Therapeutics in a seed extension to a total of £4M w/ Wren Capital, Longevitytech.fund, The Fink Family Office, Oxford Technology Management

Biotech Health services

United Kingdom

Czech Republic

Investments

05 December 2023

Share:

MitoRx Therapeutics (company)

United Kingdom

Biotech Health services

Total investments received (USD): 4.96m

Round value (USD): 4.96m

Round investors: Oxford Technology and Innovations EIS Fund Wren Capital Science Angel Syndicate Longevitytech.fund Fink Family Office

Company: MitoRx Therapeutics

Industry: Biotech Health services

Related deals

Fuse Diagnostics raises £1.6 million seed funding from a syndicate of angel investors and innovation agency Innovate UK.

Biotech Health services

United Kingdom

Investments 02 May 2024

Monument Therapeutics completed a £1.0 million fundraise with investors led by Cambridge Angels, joined by the Manchester Angels and SyndicateRoom

Biotech Health services

United Kingdom

Investments 13 April 2024

Senisca raised £3.7m with Emerging Longevity Ventures, QantX, R42 Group, Trend Investment Group, Apex Ventures and Lifespan Vision Ventures.

Biotech Health services Manufacturing Pharma

United Kingdom

Austria

China

United States

Investments 08 March 2024

Newcells Biotech raised £2.4m in funding from investors including North East Venture Fund, Mercia Ventures and Northstar Ventures.

Biotech Health services Manufacturing Pharma

United Kingdom

Investments 03 February 2024

Sable Bio raised £1.5m in pre-seed funding led by Episode1 Ventures, joined by Seedcamp.

AI (big data) Biotech Health services Software Services

United Kingdom

Investments 30 January 2024